A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tofacitinib Citrate Racemic Mixure | CAS 2664002-63-3 - 请求报价

media.product.imagealternatetextformat.details

Tofacitinib Citrate Racemic Mixure

SZ目录编号:SZ-T010094
CAS 号
2664002-63-3
分子式
C16H20N6O : C6H8O7
分子量
312.4 : 192.1
投资状态
Synthesis on demand
Rel. CAS No344418-92-4 (free base)

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Tofacitinib Citrate Racemic Mixure is chemically 3-(4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate. Tofacitinib Citrate Racemic Mixure is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Citrate Racemic Mixure can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 2664002-63-3

采购 2664002-63-3

订购 2664002-63-3

询问 2664002-63-3

price of 2664002-63-3

2664002-63-3 供应商

2664002-63-3 制造商

2664002-63-3 出口商

buy high quality Tofacitinib Citrate Racemic Mixure

采购 Tofacitinib Citrate Racemic Mixure

Tofacitinib Citrate Racemic Mixure 供应商

Tofacitinib Citrate Racemic Mixure 制造商

Tofacitinib Citrate Racemic Mixure 价格

订购 Tofacitinib Citrate Racemic Mixure

询问 Tofacitinib Citrate Racemic Mixure

Tofacitinib Citrate Racemic Mixure 成本

Tofacitinib Citrate Racemic Mixure 供应商

Tofacitinib Citrate Racemic Mixure 分销商

Tofacitinib Citrate Racemic Mixure 用于方法验证

Tofacitinib 对照标准

Tofacitinib Citrate Racemic Mixure 用于ANDA申报

Tofacitinib Citrate Racemic Mixure 用于强制降解研究

Tofacitinib Citrate Racemic Mixure 鉴别标准

Tofacitinib Citrate Racemic Mixure 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,